Hypertension is a multifactorial medical condition which essentially described as persistently
high blood pressure exceeding the normal range of blood pressure which is set at systolic …

We reviewed the Chinese and English literature for the efficacy and safety data of valsartan
monotherapy or combination therapy in Chinese hypertensive patients. According to the …

Valsartan is an angiotensin receptor antagonist that specifically blocks the angiotensin II
type 1 receptors. It is an effective and well-tolerated once-daily antihypertensive agent, with …

Angiotensin II Receptor type 1 antagonists have been widely used in treatment of diseases
like hypertension, heart failure, myocardial infarction and diabetic nephropathy. Their …

Hypertension is the most important chronic health problem. It is estimated that hypertension
affects approximately one billion people and that this number will increase by 60% until the …

Objective. To evaluate the efficacy and safety of valsartan in Taiwanese patients with
essential hypertension. Methods. This 12-week multi-center, open-label, observational, post …

Valsartan is a highly selective, orally available antagonist of the angiotensin Type 1 (AT1)
receptor. It is indicated for treatment of mild to moderate essential hypertension …

Valsartan is the second orally-active, non-peptide angiotensin II receptor blocker to reach
the market in Europe and the USA for the treatment of hypertension. Preclinical studies have …

Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …

Angiotensin receptor blockers (ARBs), also known as sartans, block the activation of
angiotensin type 1 receptors and have a recognised role in the treatment of heart failure and …